Progranulin in neurodegenerative disease
- PMID: 24800652
- DOI: 10.1016/j.tins.2014.04.003
Progranulin in neurodegenerative disease
Abstract
Loss-of-function mutations in the progranulin gene are a common cause of familial frontotemporal dementia (FTD). The purpose of this review is to summarize the role of progranulin in health and disease, because the field is now poised to begin examining therapeutics that alter endogenous progranulin levels. We first review the clinical and neuropathological phenotype of FTD patients carrying mutations in the progranulin gene, which suggests that progranulin-mediated neurodegeneration is multifactorial and influenced by other genetic and/or environmental factors. We then examine evidence for the role of progranulin in the brain with a focus on mouse model systems. A better understanding of the complexity of progranulin biology in the brain will help guide the development of progranulin-modulating therapies for neurodegenerative disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.Neurotherapeutics. 2023 Jan;20(1):140-153. doi: 10.1007/s13311-023-01348-6. Epub 2023 Feb 13. Neurotherapeutics. 2023. PMID: 36781744 Free PMC article. Review.
-
Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.Brain. 2017 May 1;140(5):1447-1465. doi: 10.1093/brain/awx060. Brain. 2017. PMID: 28379303 Free PMC article.
-
Core neuropathological abnormalities in progranulin-deficient mice are penetrant on multiple genetic backgrounds.Neuroscience. 2016 Feb 19;315:175-95. doi: 10.1016/j.neuroscience.2015.12.006. Epub 2015 Dec 14. Neuroscience. 2016. PMID: 26701296
-
Synaptic dysfunction in progranulin-deficient mice.Neurobiol Dis. 2012 Feb;45(2):711-22. doi: 10.1016/j.nbd.2011.10.016. Epub 2011 Oct 25. Neurobiol Dis. 2012. PMID: 22062772
-
Progranulin, lysosomal regulation and neurodegenerative disease.Nat Rev Neurosci. 2017 Jun;18(6):325-333. doi: 10.1038/nrn.2017.36. Epub 2017 Apr 24. Nat Rev Neurosci. 2017. PMID: 28435163 Free PMC article. Review.
Cited by
-
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.Mol Neurodegener. 2016 Jun 24;11(1):46. doi: 10.1186/s13024-016-0114-3. Mol Neurodegener. 2016. PMID: 27341800 Free PMC article.
-
FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.J Neuropathol Exp Neurol. 2019 Sep 1;78(9):844-853. doi: 10.1093/jnen/nlz059. J Neuropathol Exp Neurol. 2019. PMID: 31361008 Free PMC article.
-
Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.Hum Mol Genet. 2020 Mar 27;29(5):716-726. doi: 10.1093/hmg/ddz229. Hum Mol Genet. 2020. PMID: 31600775 Free PMC article.
-
Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics.Ann Clin Transl Neurol. 2019 Mar 7;6(4):698-707. doi: 10.1002/acn3.745. eCollection 2019 Apr. Ann Clin Transl Neurol. 2019. PMID: 31019994 Free PMC article.
-
Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.Breast Cancer Res Treat. 2021 Apr;186(3):637-653. doi: 10.1007/s10549-021-06120-y. Epub 2021 Feb 22. Breast Cancer Res Treat. 2021. PMID: 33616772 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous